These observations also support the necessity of new strategies for HIV and STI control such as early universal access to antiretroviral therapy, irrespective of CD4 count, and Pre-exposure prophylaxis (PrEP) for key populations [25]. Here, CD4 is linked to sexually transmitted disease.